This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Streamline Health Solutions' CEO Discusses Q1 2011 Results - Earnings Call Transcript

Stocks in this article: STRM

I indicated to you, on the previous quarter's call, that immediately upon joining Streamline Health, I engaged in a thorough review of the solutions, the operations and the personnel of the company. With the benefit of an entire quarter under my belt, I am fully convinced that Streamline Health has a solid portfolio of solutions and services that will support healthcare organizations in driving operational and financial efficiencies and that our solutions assist healthcare organizations in meeting the requirements of meaningful use. As we discussed before, meeting these requirements helps to make our clients eligible for significant incentive payments as outlined in the HITECH Act.

After visiting or talking with many of our clients, I've discovered they share my beliefs that Streamline Health offers a strong value proposition that provides significant cost efficiencies, given our deep and meaningful integration with EMR vendors such as GE, Cerner, Allscripts, MediTech and Epic. From a solutions positioning standpoint, we have a clear and leverageable advantage in the marketplace, given the depth of our integration work. I've also discovered that our clients highly value the operational and technical support that our associates provide, and many of them have come to view us as a true partner who works to see them be successful. Our legacy as a Health Information Management-oriented company has successfully differentiated us from other vendors who went through the healthcare vertical from another industry focus. The importance of this legacy became evident last quarter when we saw 2 clients resist internal IT department pressure to change to a new document management system that was bundled into the deployment of a new electronic medical record system within their respective facilities. These clients stayed with Streamline Health's best-of-breed solution set rather than settling for a single-source IT product that had fewer capabilities and less functionality.

3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,684.76 +12.16 0.07%
S&P 500 2,054.17 +2.35 0.11%
NASDAQ 4,766.0690 +8.19 0.17%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs